These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

751 related articles for article (PubMed ID: 26922471)

  • 21. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].
    Diaz MC; Camponovo R; Araya I; Cerda A; Santander MP; Carrillo-Muñoz AJ
    Rev Esp Quimioter; 2016 Jun; 29(3):151-4. PubMed ID: 27167765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
    Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
    J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Characterization of Candida africana in Genital Specimens in Shanghai, China.
    Hu Y; Yu A; Chen X; Wang G; Feng X
    Biomed Res Int; 2015; 2015():185387. PubMed ID: 26665002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.
    Bitew A; Abebaw Y
    BMC Womens Health; 2018 Jun; 18(1):94. PubMed ID: 29902998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution, antifungal susceptibility pattern and intra-Candida albicans species complex prevalence of Candida africana: A systematic review and meta-analysis.
    Gharehbolagh SA; Fallah B; Izadi A; Ardestani ZS; Malekifar P; M Borman A; Mahmoudi S
    PLoS One; 2020; 15(8):e0237046. PubMed ID: 32817677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012.
    Liu XP; Fan SR; Peng YT; Zhang HP
    J Mycol Med; 2014 Jun; 24(2):106-11. PubMed ID: 24746725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of Biofilm-Related Genes and Antifungal Susceptibility Pattern of Vaginal
    Mohammadi F; Hemmat N; Bajalan Z; Javadi A
    Biomed Res Int; 2021; 2021():5598907. PubMed ID: 34136569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of resistance and sensitivity of 1 200 strains of vulvovaginal candidiasis in China to five common antifungal drugs].
    Fan LY; Liu ZH; Bai XN; Zong X
    Zhonghua Fu Chan Ke Za Zhi; 2022 Aug; 57(8):601-607. PubMed ID: 36008287
    [No Abstract]   [Full Text] [Related]  

  • 30. Candida africana vulvovaginitis: Prevalence and geographical distribution.
    Fakhim H; Vaezi A; Javidnia J; Nasri E; Mahdi D; Diba K; Badali H
    J Mycol Med; 2020 Sep; 30(3):100966. PubMed ID: 32317216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multilocus sequence typing of Candida africana from patients with vulvovaginal candidiasis in New Delhi, India.
    Sharma C; Muralidhar S; Xu J; Meis JF; Chowdhary A
    Mycoses; 2014 Sep; 57(9):544-52. PubMed ID: 24697839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Vitro Antifungal Susceptibility Profiles of Candida albicans Complex Isolated from Patients with Respiratory Infections.
    Sharifynia S; Badali H; Sharifi Sorkherizi M; Shidfar MR; Hadian A; Shahrokhi S; Ghandchi G; Rezaie S
    Acta Med Iran; 2016 Jun; 54(6):376-81. PubMed ID: 27306344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antifungal Susceptibility Profile of Candida Albicans Isolated from Vulvovaginal Candidiasis in Xinjiang Province of China.
    Yan L; Wang XD; Seyedmousavi S; Yuan JN; Abulize P; Pan WH; Yu N; Yang YL; Hu HQ; Liao WQ; Deng SW
    Mycopathologia; 2019 Jun; 184(3):413-422. PubMed ID: 30968320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and antifungal susceptibility of Candida species in a tertiary care hospital in Islamabad, Pakistan.
    Tasneem U; Siddiqui MT; Faryal R; Shah AA
    J Pak Med Assoc; 2017 Jul; 67(7):986-991. PubMed ID: 28770873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
    Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
    Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the in vitro activity of echinocandins against Candida albicans, Candida dubliniensis, and Candida africana by time-kill curves.
    Gil-Alonso S; Jauregizar N; Cantón E; Eraso E; Quindós G
    Diagn Microbiol Infect Dis; 2015 May; 82(1):57-61. PubMed ID: 25703894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
    Fan SR; Liu XP; Li JW
    J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exoenzyme activity and possibility identification of Candida dubliniensis among Candida albicans species isolated from vaginal candidiasis.
    Jafari M; Salari S; Pakshir K; Zomorodian K
    Microb Pathog; 2017 Sep; 110():73-77. PubMed ID: 28642006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis.
    Hacioglu M; Guzel CB; Savage PB; Tan ASB
    Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifungal susceptibility pattern of
    Ali M; Edrees WH; Al-Shehari WA; Xue G; Al-Hammadi S; Qasem EA; Chaulagain RP; Lal N
    Front Cell Infect Microbiol; 2024; 14():1434677. PubMed ID: 39170986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.